Found 13 matching trials
Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure
PHASE2This is a multi-centre, phase II, open-label, 12-month clinical trial for p...
Location
The Prostate Centre Princess Margaret Hospital
Study Using WST11 in Patients With Localized Prostate Cancer
PHASE2The aim of this trial is to determine the optimal treatment conditions to a...
Location
Centre Hospitalier Universitaire (CHU)
Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer
PHASE4Multiple center, single-arm, open-label, 12-month follow-up phase IV pragma...
Location
Centre Hospitalier Universitaire (CHU)
European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up
N/AThis is an open observational extended follow-up study of patients original...
Location
Department of Urology-Tampere University Hospital-
Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer
PHASE3The aim of this study is to confirm the Efficacy,the Safety and the Quality...
Location
Hospital General Tlahuac
Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy
PHASE2The aim of this clinical trial is to evaluate the efficacy and safety of th...
Location
Princess Margaret Hospital
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
PHASE3Multi-center, prospective, randomized controlled clinical trial that will c...
Location
Memorial Sloan-Kettering Cancer Center
Study of WST11 in Patients With Localized Prostate Cancer
PHASE2The aim of this clinical study is to determine the optimal treatment condit...
Location
University Health Network-Princess Margaret Hospital
Vascular Targeted Photodynamic Therapy T1a Renal Tumours
PHASE1Vascular Targeted Photodynamic therapy (VTP) with the Vascular Occluding Ag...
Location
Churchill Hospital
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.
PHASE2Single center, single-arm, open-label, 60-month follow-up phase IIb clinica...
Status
Active Not Recruiting
Location
Memorial Sloan-Kettering Cancer Center